nodes	percent_of_prediction	percent_of_DWPC	metapath
Trihexyphenidyl—Sinus bradycardia—Pazopanib—kidney cancer	0.0494	0.0506	CcSEcCtD
Trihexyphenidyl—Ileus paralytic—Vinblastine—kidney cancer	0.0444	0.0454	CcSEcCtD
Trihexyphenidyl—Ileus paralytic—Vincristine—kidney cancer	0.0312	0.032	CcSEcCtD
Trihexyphenidyl—Blindness—Sunitinib—kidney cancer	0.0288	0.0295	CcSEcCtD
Trihexyphenidyl—Ileus paralytic—Paclitaxel—kidney cancer	0.0248	0.0254	CcSEcCtD
Trihexyphenidyl—Blindness—Vincristine—kidney cancer	0.0244	0.025	CcSEcCtD
Trihexyphenidyl—Sinus bradycardia—Paclitaxel—kidney cancer	0.0219	0.0224	CcSEcCtD
Trihexyphenidyl—CHRM3—ureter—kidney cancer	0.0206	0.865	CbGeAlD
Trihexyphenidyl—Ileus paralytic—Capecitabine—kidney cancer	0.0203	0.0208	CcSEcCtD
Trihexyphenidyl—Dry skin—Temsirolimus—kidney cancer	0.0171	0.0175	CcSEcCtD
Trihexyphenidyl—Dry skin—Pazopanib—kidney cancer	0.0161	0.0165	CcSEcCtD
Trihexyphenidyl—Weight decreased—Temsirolimus—kidney cancer	0.0146	0.0149	CcSEcCtD
Trihexyphenidyl—Weight decreased—Pazopanib—kidney cancer	0.0137	0.0141	CcSEcCtD
Trihexyphenidyl—Dry skin—Everolimus—kidney cancer	0.0127	0.013	CcSEcCtD
Trihexyphenidyl—Dry skin—Erlotinib—kidney cancer	0.0123	0.0126	CcSEcCtD
Trihexyphenidyl—Memory impairment—Capecitabine—kidney cancer	0.0112	0.0115	CcSEcCtD
Trihexyphenidyl—Dry skin—Sorafenib—kidney cancer	0.011	0.0113	CcSEcCtD
Trihexyphenidyl—Weight decreased—Everolimus—kidney cancer	0.0108	0.0111	CcSEcCtD
Trihexyphenidyl—Dry skin—Sunitinib—kidney cancer	0.0106	0.0109	CcSEcCtD
Trihexyphenidyl—Weight decreased—Erlotinib—kidney cancer	0.0105	0.0107	CcSEcCtD
Trihexyphenidyl—Blindness—Doxorubicin—kidney cancer	0.0102	0.0105	CcSEcCtD
Trihexyphenidyl—Vision blurred—Pazopanib—kidney cancer	0.00997	0.0102	CcSEcCtD
Trihexyphenidyl—Hallucination—Everolimus—kidney cancer	0.00955	0.00978	CcSEcCtD
Trihexyphenidyl—Weight decreased—Sorafenib—kidney cancer	0.00942	0.00965	CcSEcCtD
Trihexyphenidyl—Weight decreased—Sunitinib—kidney cancer	0.00906	0.00928	CcSEcCtD
Trihexyphenidyl—Somnolence—Temsirolimus—kidney cancer	0.00815	0.00835	CcSEcCtD
Trihexyphenidyl—Vision blurred—Everolimus—kidney cancer	0.00787	0.00807	CcSEcCtD
Trihexyphenidyl—Constipation—Temsirolimus—kidney cancer	0.00784	0.00803	CcSEcCtD
Trihexyphenidyl—Agitation—Everolimus—kidney cancer	0.00768	0.00787	CcSEcCtD
Trihexyphenidyl—Somnolence—Pazopanib—kidney cancer	0.00768	0.00786	CcSEcCtD
Trihexyphenidyl—Weight decreased—Vincristine—kidney cancer	0.00766	0.00785	CcSEcCtD
Trihexyphenidyl—Dry skin—Paclitaxel—kidney cancer	0.00714	0.00731	CcSEcCtD
Trihexyphenidyl—Hallucination—Vincristine—kidney cancer	0.00675	0.00691	CcSEcCtD
Trihexyphenidyl—Tachycardia—Everolimus—kidney cancer	0.00665	0.00682	CcSEcCtD
Trihexyphenidyl—Asthenia—Temsirolimus—kidney cancer	0.00658	0.00674	CcSEcCtD
Trihexyphenidyl—Asthenia—Pazopanib—kidney cancer	0.0062	0.00635	CcSEcCtD
Trihexyphenidyl—Weight decreased—Paclitaxel—kidney cancer	0.00609	0.00624	CcSEcCtD
Trihexyphenidyl—Somnolence—Everolimus—kidney cancer	0.00606	0.00621	CcSEcCtD
Trihexyphenidyl—Dizziness—Temsirolimus—kidney cancer	0.00606	0.00621	CcSEcCtD
Trihexyphenidyl—Dry skin—Capecitabine—kidney cancer	0.00586	0.006	CcSEcCtD
Trihexyphenidyl—Constipation—Vinblastine—kidney cancer	0.00585	0.006	CcSEcCtD
Trihexyphenidyl—Constipation—Everolimus—kidney cancer	0.00583	0.00597	CcSEcCtD
Trihexyphenidyl—Vomiting—Temsirolimus—kidney cancer	0.00583	0.00597	CcSEcCtD
Trihexyphenidyl—Rash—Temsirolimus—kidney cancer	0.00578	0.00592	CcSEcCtD
Trihexyphenidyl—Dermatitis—Temsirolimus—kidney cancer	0.00577	0.00592	CcSEcCtD
Trihexyphenidyl—Headache—Temsirolimus—kidney cancer	0.00574	0.00588	CcSEcCtD
Trihexyphenidyl—Dizziness—Pazopanib—kidney cancer	0.00571	0.00585	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Vinblastine—kidney cancer	0.00564	0.00578	CcSEcCtD
Trihexyphenidyl—Constipation—Erlotinib—kidney cancer	0.00563	0.00576	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Everolimus—kidney cancer	0.00562	0.00576	CcSEcCtD
Trihexyphenidyl—Vomiting—Pazopanib—kidney cancer	0.00549	0.00563	CcSEcCtD
Trihexyphenidyl—Rash—Pazopanib—kidney cancer	0.00545	0.00558	CcSEcCtD
Trihexyphenidyl—Nausea—Temsirolimus—kidney cancer	0.00544	0.00558	CcSEcCtD
Trihexyphenidyl—Dermatitis—Pazopanib—kidney cancer	0.00544	0.00557	CcSEcCtD
Trihexyphenidyl—Agitation—Vincristine—kidney cancer	0.00542	0.00556	CcSEcCtD
Trihexyphenidyl—Headache—Pazopanib—kidney cancer	0.00541	0.00554	CcSEcCtD
Trihexyphenidyl—Nausea—Pazopanib—kidney cancer	0.00513	0.00525	CcSEcCtD
Trihexyphenidyl—Constipation—Sorafenib—kidney cancer	0.00506	0.00519	CcSEcCtD
Trihexyphenidyl—Weight decreased—Capecitabine—kidney cancer	0.005	0.00512	CcSEcCtD
Trihexyphenidyl—Asthenia—Vinblastine—kidney cancer	0.00491	0.00503	CcSEcCtD
Trihexyphenidyl—Asthenia—Everolimus—kidney cancer	0.00489	0.00501	CcSEcCtD
Trihexyphenidyl—Constipation—Sunitinib—kidney cancer	0.00487	0.00499	CcSEcCtD
Trihexyphenidyl—Asthenia—Erlotinib—kidney cancer	0.00472	0.00484	CcSEcCtD
Trihexyphenidyl—Tension—Paclitaxel—kidney cancer	0.0046	0.00471	CcSEcCtD
Trihexyphenidyl—Nervousness—Paclitaxel—kidney cancer	0.00455	0.00466	CcSEcCtD
Trihexyphenidyl—Dizziness—Vinblastine—kidney cancer	0.00453	0.00464	CcSEcCtD
Trihexyphenidyl—Dizziness—Everolimus—kidney cancer	0.00451	0.00462	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Dactinomycin—kidney cancer	0.00444	0.00455	CcSEcCtD
Trihexyphenidyl—Vision blurred—Paclitaxel—kidney cancer	0.00442	0.00453	CcSEcCtD
Trihexyphenidyl—Vomiting—Vinblastine—kidney cancer	0.00435	0.00446	CcSEcCtD
Trihexyphenidyl—Dizziness—Erlotinib—kidney cancer	0.00435	0.00446	CcSEcCtD
Trihexyphenidyl—Vomiting—Everolimus—kidney cancer	0.00434	0.00444	CcSEcCtD
Trihexyphenidyl—Agitation—Paclitaxel—kidney cancer	0.00431	0.00441	CcSEcCtD
Trihexyphenidyl—Rash—Everolimus—kidney cancer	0.0043	0.0044	CcSEcCtD
Trihexyphenidyl—Dermatitis—Everolimus—kidney cancer	0.0043	0.0044	CcSEcCtD
Trihexyphenidyl—Headache—Vinblastine—kidney cancer	0.00429	0.00439	CcSEcCtD
Trihexyphenidyl—Headache—Everolimus—kidney cancer	0.00427	0.00438	CcSEcCtD
Trihexyphenidyl—Asthenia—Sorafenib—kidney cancer	0.00425	0.00435	CcSEcCtD
Trihexyphenidyl—Vomiting—Erlotinib—kidney cancer	0.00418	0.00429	CcSEcCtD
Trihexyphenidyl—Rash—Erlotinib—kidney cancer	0.00415	0.00425	CcSEcCtD
Trihexyphenidyl—Dermatitis—Erlotinib—kidney cancer	0.00414	0.00425	CcSEcCtD
Trihexyphenidyl—Headache—Erlotinib—kidney cancer	0.00412	0.00422	CcSEcCtD
Trihexyphenidyl—Constipation—Vincristine—kidney cancer	0.00412	0.00422	CcSEcCtD
Trihexyphenidyl—Asthenia—Sunitinib—kidney cancer	0.00409	0.00419	CcSEcCtD
Trihexyphenidyl—Nausea—Vinblastine—kidney cancer	0.00407	0.00417	CcSEcCtD
Trihexyphenidyl—Somnolence—Gemcitabine—kidney cancer	0.00406	0.00416	CcSEcCtD
Trihexyphenidyl—Nausea—Everolimus—kidney cancer	0.00405	0.00415	CcSEcCtD
Trihexyphenidyl—Dizziness—Sorafenib—kidney cancer	0.00391	0.00401	CcSEcCtD
Trihexyphenidyl—Constipation—Gemcitabine—kidney cancer	0.00391	0.004	CcSEcCtD
Trihexyphenidyl—Nausea—Erlotinib—kidney cancer	0.00391	0.004	CcSEcCtD
Trihexyphenidyl—Asthenia—Dactinomycin—kidney cancer	0.00387	0.00396	CcSEcCtD
Trihexyphenidyl—Confusional state—Paclitaxel—kidney cancer	0.00386	0.00395	CcSEcCtD
Trihexyphenidyl—Dry skin—Doxorubicin—kidney cancer	0.00377	0.00387	CcSEcCtD
Trihexyphenidyl—Dizziness—Sunitinib—kidney cancer	0.00377	0.00386	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Gemcitabine—kidney cancer	0.00377	0.00386	CcSEcCtD
Trihexyphenidyl—Vomiting—Sorafenib—kidney cancer	0.00376	0.00386	CcSEcCtD
Trihexyphenidyl—Tachycardia—Paclitaxel—kidney cancer	0.00373	0.00383	CcSEcCtD
Trihexyphenidyl—Rash—Sorafenib—kidney cancer	0.00373	0.00382	CcSEcCtD
Trihexyphenidyl—Dermatitis—Sorafenib—kidney cancer	0.00373	0.00382	CcSEcCtD
Trihexyphenidyl—Headache—Sorafenib—kidney cancer	0.00371	0.0038	CcSEcCtD
Trihexyphenidyl—Vision blurred—Capecitabine—kidney cancer	0.00363	0.00371	CcSEcCtD
Trihexyphenidyl—Vomiting—Sunitinib—kidney cancer	0.00362	0.00371	CcSEcCtD
Trihexyphenidyl—Rash—Sunitinib—kidney cancer	0.00359	0.00368	CcSEcCtD
Trihexyphenidyl—Dermatitis—Sunitinib—kidney cancer	0.00359	0.00368	CcSEcCtD
Trihexyphenidyl—Headache—Sunitinib—kidney cancer	0.00357	0.00366	CcSEcCtD
Trihexyphenidyl—Nausea—Sorafenib—kidney cancer	0.00352	0.0036	CcSEcCtD
Trihexyphenidyl—Asthenia—Vincristine—kidney cancer	0.00346	0.00354	CcSEcCtD
Trihexyphenidyl—Vomiting—Dactinomycin—kidney cancer	0.00343	0.00351	CcSEcCtD
Trihexyphenidyl—Somnolence—Paclitaxel—kidney cancer	0.0034	0.00348	CcSEcCtD
Trihexyphenidyl—Rash—Dactinomycin—kidney cancer	0.0034	0.00348	CcSEcCtD
Trihexyphenidyl—Nausea—Sunitinib—kidney cancer	0.00338	0.00347	CcSEcCtD
Trihexyphenidyl—Asthenia—Gemcitabine—kidney cancer	0.00328	0.00336	CcSEcCtD
Trihexyphenidyl—Constipation—Paclitaxel—kidney cancer	0.00327	0.00335	CcSEcCtD
Trihexyphenidyl—Weight decreased—Doxorubicin—kidney cancer	0.00322	0.0033	CcSEcCtD
Trihexyphenidyl—Nausea—Dactinomycin—kidney cancer	0.0032	0.00328	CcSEcCtD
Trihexyphenidyl—Dizziness—Vincristine—kidney cancer	0.00319	0.00326	CcSEcCtD
Trihexyphenidyl—Drowsiness—Doxorubicin—kidney cancer	0.00317	0.00325	CcSEcCtD
Trihexyphenidyl—Confusional state—Capecitabine—kidney cancer	0.00317	0.00324	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Paclitaxel—kidney cancer	0.00315	0.00323	CcSEcCtD
Trihexyphenidyl—Tachycardia—Capecitabine—kidney cancer	0.00306	0.00314	CcSEcCtD
Trihexyphenidyl—Vomiting—Vincristine—kidney cancer	0.00306	0.00314	CcSEcCtD
Trihexyphenidyl—Rash—Vincristine—kidney cancer	0.00304	0.00311	CcSEcCtD
Trihexyphenidyl—Dermatitis—Vincristine—kidney cancer	0.00303	0.00311	CcSEcCtD
Trihexyphenidyl—Headache—Vincristine—kidney cancer	0.00302	0.00309	CcSEcCtD
Trihexyphenidyl—Vomiting—Gemcitabine—kidney cancer	0.00291	0.00298	CcSEcCtD
Trihexyphenidyl—Rash—Gemcitabine—kidney cancer	0.00288	0.00295	CcSEcCtD
Trihexyphenidyl—Dermatitis—Gemcitabine—kidney cancer	0.00288	0.00295	CcSEcCtD
Trihexyphenidyl—Headache—Gemcitabine—kidney cancer	0.00286	0.00293	CcSEcCtD
Trihexyphenidyl—Nausea—Vincristine—kidney cancer	0.00286	0.00293	CcSEcCtD
Trihexyphenidyl—Asthenia—Paclitaxel—kidney cancer	0.00275	0.00281	CcSEcCtD
Trihexyphenidyl—Nausea—Gemcitabine—kidney cancer	0.00271	0.00278	CcSEcCtD
Trihexyphenidyl—Constipation—Capecitabine—kidney cancer	0.00269	0.00275	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Capecitabine—kidney cancer	0.00259	0.00265	CcSEcCtD
Trihexyphenidyl—Dizziness—Paclitaxel—kidney cancer	0.00253	0.00259	CcSEcCtD
Trihexyphenidyl—Tension—Doxorubicin—kidney cancer	0.00243	0.00249	CcSEcCtD
Trihexyphenidyl—Vomiting—Paclitaxel—kidney cancer	0.00243	0.00249	CcSEcCtD
Trihexyphenidyl—Rash—Paclitaxel—kidney cancer	0.00241	0.00247	CcSEcCtD
Trihexyphenidyl—Dermatitis—Paclitaxel—kidney cancer	0.00241	0.00247	CcSEcCtD
Trihexyphenidyl—Nervousness—Doxorubicin—kidney cancer	0.00241	0.00247	CcSEcCtD
Trihexyphenidyl—Headache—Paclitaxel—kidney cancer	0.0024	0.00246	CcSEcCtD
Trihexyphenidyl—Vision blurred—Doxorubicin—kidney cancer	0.00234	0.00239	CcSEcCtD
Trihexyphenidyl—Agitation—Doxorubicin—kidney cancer	0.00228	0.00233	CcSEcCtD
Trihexyphenidyl—Nausea—Paclitaxel—kidney cancer	0.00227	0.00233	CcSEcCtD
Trihexyphenidyl—Asthenia—Capecitabine—kidney cancer	0.00225	0.00231	CcSEcCtD
Trihexyphenidyl—Dizziness—Capecitabine—kidney cancer	0.00208	0.00213	CcSEcCtD
Trihexyphenidyl—Confusional state—Doxorubicin—kidney cancer	0.00204	0.00209	CcSEcCtD
Trihexyphenidyl—Vomiting—Capecitabine—kidney cancer	0.002	0.00205	CcSEcCtD
Trihexyphenidyl—Rash—Capecitabine—kidney cancer	0.00198	0.00203	CcSEcCtD
Trihexyphenidyl—Dermatitis—Capecitabine—kidney cancer	0.00198	0.00203	CcSEcCtD
Trihexyphenidyl—Tachycardia—Doxorubicin—kidney cancer	0.00198	0.00202	CcSEcCtD
Trihexyphenidyl—Headache—Capecitabine—kidney cancer	0.00197	0.00202	CcSEcCtD
Trihexyphenidyl—Nausea—Capecitabine—kidney cancer	0.00187	0.00191	CcSEcCtD
Trihexyphenidyl—Somnolence—Doxorubicin—kidney cancer	0.0018	0.00184	CcSEcCtD
Trihexyphenidyl—Constipation—Doxorubicin—kidney cancer	0.00173	0.00177	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Doxorubicin—kidney cancer	0.00167	0.00171	CcSEcCtD
Trihexyphenidyl—CHRM3—renal system—kidney cancer	0.00164	0.0687	CbGeAlD
Trihexyphenidyl—CHRM3—kidney—kidney cancer	0.00158	0.0664	CbGeAlD
Trihexyphenidyl—Asthenia—Doxorubicin—kidney cancer	0.00145	0.00149	CcSEcCtD
Trihexyphenidyl—Dizziness—Doxorubicin—kidney cancer	0.00134	0.00137	CcSEcCtD
Trihexyphenidyl—Vomiting—Doxorubicin—kidney cancer	0.00129	0.00132	CcSEcCtD
Trihexyphenidyl—Rash—Doxorubicin—kidney cancer	0.00128	0.00131	CcSEcCtD
Trihexyphenidyl—Dermatitis—Doxorubicin—kidney cancer	0.00127	0.00131	CcSEcCtD
Trihexyphenidyl—Headache—Doxorubicin—kidney cancer	0.00127	0.0013	CcSEcCtD
Trihexyphenidyl—Nausea—Doxorubicin—kidney cancer	0.0012	0.00123	CcSEcCtD
